12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

CardioSCORE: Pivotal trial data

Data from the U.S. pivotal BioImage Study in 6,600 subjects with no prior history of cardiovascular disease showed that testing with BG Medicine's CardioSCORE diagnostic at baseline significantly improved the identification of subjects at high risk for near-term major cardiovascular events over conventional risk scoring throughout a median follow-up of 2.5 years. Specifically, the addition...

Read the full 252 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >